Christoph Roderburg

12PUBLICATIONS
3CO-AUTHORS
Nutritional epidemiologyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMajor global burdens of diseasePacific Peoples cultural determinants of health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Oct 28, 2024
The nexus between appendicitis and chronic inflammatory bowel diseases: Unraveling an intriguing association.

Christoph Roderburg, Sven H Loosen, Petra May

|May 22, 2023
Study protocol of an open-label, single arm phase II trial investigating the efficacy and safety of Trifluridine/Tipiracil combined with irinotecan as a second line therapy in patients with cholangiocarcinoma (TRITICC).

Linde Kehmann, Marie-Luise Berres, Maria Gonzalez-Carmona

|Dec 23, 2022
Clinical characteristics of 662 patients with pancreatic neuroendocrine tumors receiving antitumoral therapy.

Sven H Loosen, Karel Kostev, Johannes Eschrich

|Dec 12, 2022
Elevated Serum Levels of CCL23 Are Associated with Poor Outcome after Resection of Biliary Tract Cancer.

Christoph Roderburg, Simon Labuhn, Jan Bednarsch

|Apr 27, 2022
Distribution of gastrointestinal neuroendocrine tumors in Europe: results from a retrospective cross-sectional study.

Sven H Loosen, Karel Kostev, Henning Jann

|Apr 20, 2022
Antibiotic therapy is associated with an increased incidence of cancer.

Christoph Roderburg, Sven H Loosen, Markus S Joerdens

Pageof 2

Frequent Collaborators

1 joint publications

Frank Tacke

1 joint publications

Tom Luedde

1 joint publications

Sven H Loosen